The store will not work correctly when cookies are disabled.
3-{[(5-Chloro-3-methyl-1-benzothiophen-2-yl)sulfonyl]amino}-2-hydroxybenzoic acid
ID: ALA3729923
PubChem CID: 66799978
Max Phase: Preclinical
Molecular Formula: C16H12ClNO5S2
Molecular Weight: 397.86
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1c(S(=O)(=O)Nc2cccc(C(=O)O)c2O)sc2ccc(Cl)cc12
Standard InChI: InChI=1S/C16H12ClNO5S2/c1-8-11-7-9(17)5-6-13(11)24-16(8)25(22,23)18-12-4-2-3-10(14(12)19)15(20)21/h2-7,18-19H,1H3,(H,20,21)
Standard InChI Key: CZVOXGSVQNCHHF-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
-0.4916 -3.8582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3114 -2.9665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8032 -3.1233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4133 -1.7530 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3383 1.3500 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5524 -4.4208 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
3.7524 -4.4204 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.1529 -5.4597 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.8028 -5.7210 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5532 -7.0208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0533 -7.0178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8059 -8.3153 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0586 -9.6159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5586 -9.6189 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8135 -10.9217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4171 -11.9589 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.6135 -10.9263 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.8059 -8.3214 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6059 -8.3239 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
8 10 1 0
10 11 2 0
11 2 1 0
11 5 1 0
3 12 1 0
12 13 2 0
12 14 2 0
12 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 1 0
21 22 2 0
21 23 1 0
20 24 2 0
24 16 1 0
24 25 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 397.86 | Molecular Weight (Monoisotopic): 396.9845 | AlogP: 4.07 | #Rotatable Bonds: 4 |
Polar Surface Area: 103.70 | Molecular Species: ACID | HBA: 5 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 2.68 | CX Basic pKa: ┄ | CX LogP: 5.27 | CX LogD: 0.92 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.58 | Np Likeness Score: -1.18 |
References
1. (2012) New compounds, |
2. (2016) Sulfonamide compounds, |